Christina L. Zuch de Zafra
Pfizer (United States)(US)Universidad de Extremadura(ES)
Publications by Year
Research Areas
Monoclonal and Polyclonal Antibodies Research, CAR-T cell therapy research, HER2/EGFR in Cancer Research, Cancer Treatment and Pharmacology, Synthesis and Biological Evaluation
Most-Cited Works
- → Targeting Multiple Myeloma with AMG 424, a Novel Anti-CD38/CD3 Bispecific T-cell–recruiting Antibody Optimized for Cytotoxicity and Cytokine Release(2019)123 cited
- → Target arm affinities determine preclinical efficacy and safety of anti-HER2/CD3 bispecific antibody(2020)96 cited
- → Host cell proteins in biotechnology‐derived products: A risk assessment framework(2015)65 cited
- → Inflammation and immunogenicity limit the utility of the rabbit as a nonclinical species for ocular biologic therapeutics(2017)39 cited
- → Mitigation of Oxidation in Therapeutic Antibody Formulations: a Biochemical Efficacy and Safety Evaluation of N-Acetyl-Tryptophan and L-Methionine(2018)38 cited
- → Balancing Efficacy and Safety of an Anti-DLL4 Antibody through Pharmacokinetic Modulation(2015)25 cited
- → Antitherapeutic antibody-mediated hepatotoxicity of recombinant human Apo2L/TRAIL in the cynomolgus monkey(2016)21 cited
- → Rapid Development of Glaucoma Via ITV Nonselective ANGPT 1/2 Antibody: A Potential Role for ANGPT/TIE2 Signaling in Primate Aqueous Humor Outflow(2019)18 cited
- → The Vedotin Antibody–Drug Conjugate Payload Drives Platform-Based Nonclinical Safety and Pharmacokinetic Profiles(2024)17 cited
- → Antiulcer and Antidiarrhoeic Effect of Baccharis teindalensis(2003)16 cited